Skip to main content

Impel NeuroPharma, Inc. (IMPL)

NASDAQ: IMPL · IEX Real-Time Price · USD
9.60
0.28 (3.00%)
At close: Nov 26, 2021 1:00 PM
9.61
0.01 (0.10%)
After-hours:Nov 26, 2021 4:59 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
18.0512.75
Research & Development
27.2928.81
Operating Expenses
45.3341.57
Operating Income
-45.33-41.57
Interest Expense / Income
0.06-0.42
Other Expense / Income
0.410.68
Pretax Income
-45.8-41.83
Income Tax
00.03
Net Income
-45.8-41.86
Preferred Dividends
0.520.51
Net Income Common
-46.32-42.36
Shares Outstanding (Basic)
10
Shares Outstanding (Diluted)
10
Shares Change
46.57%-
EPS (Basic)
-91.05-122.07
EPS (Diluted)
-91.05-122.07
Free Cash Flow Per Share
-80.53-109.53
Effective Tax Rate
-0.00%-0.07%
EBITDA
-44.67-41.52
EBIT
-45.74-42.25
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).